Close
Nordic 9Nordic 9

i&i Biotech Fund (investor - Others)

Luxembourg inibio.eu
See something wrong or missing? Let us know
Offices:Luxembourg

i&i Biotech Fund is a Luxembourg-based tech transfer fund focused on Life Sciences.

Average round investment:7.04M USD
Average number per year:2.0
Distribution: 2025 (1)2024 (2)2023 (2)2022 (3)
Portfolio companies: Spain NanoligentUnited Kingdom AntiverseGermany Captain T Cell See the entire list
Mostly invests in: Spain Spain (2) Biotech (6)
See the entire list

Showing 3 of 8 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to i&i Biotech Fund

Name Criteria
United Kingdom Eos Venture Partners
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, AI (big data), Electronics
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Pwc
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data), Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Austria, United Kingdom, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Holly Branson
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Ataraxia
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Spain, United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany BLN Capital
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Investitions- und Förderbank
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Health services, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Hawktail
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States Voyager VC
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Israel Avi Meir
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: Spain, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany BayWa re Energy Ventures
92%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Software Services, Manufacturing, Electronics, Hardware
  • Similar business models: B2B, SAAS
  • Common investees countries: Spain, Austria, Germany
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top